It has been shown that pulmonary macrophage (PM) phagocytosis of Pseudomonas aeruginosa (PA) is inhibited in the presence of serum from cystic fibrosis (CF) patients colonized by Pseudomonas, and that these sera contain high concentrations of IgG2 antibodies. The goal of these studies was to investigate the role that IgG2-containing immune complexes (IC) play in this inhibition of both PM and neutrophil phagocytosis. We found that serum IgG2 concentrations were elevated significantly in CF patients with chronic PA colonization and that in selected sera from CF patients with chronic PA colonization (CF + IC, n = 10), the mean IC level was significantly elevated 
(2.90±0.22 mg/dl ISEM1). IgG2 comprised 74.5% of IgG precipitated in IC from CF + IC sera. An invitro phagocytic assay of ['4CJPA uptake using CF + IC whole-sera opsonins con- firmed that endocytosis by normal PM and neutrophils was significantly depressed. Removal of IC from CF + IC sera resulted in significantly decreased serum IgG2 concentrations without a significant change in the other subclass concentrations, and enhanced ["CIPA uptake by PM (26.6% uptake increased to 47.3%) and neutrophils (16.9% increased to 52.6%). Return of the soluble IgG2 IC to the original CF sera supernatants and the positive control sera resulted in return of the inhibitory capacity of the CF + IC sera. We conclude that immune sera from patients with chronic Pseudomonas infections characterized by elevated IgG2 subclass level functions poorly as an opsonin. In these individuals, IgG2 contributes significantly to circulating IC and removal of IC, matched by a simultaneous fall in IgG2, improves bacterial uptake by neutrophil and mononuclear phagocytes. IgG2 antibodies exert antiphagocytic effects by both direct inhibition and the formation of IC. (J. Clin. Invest. 1990 . 86:1285-1292.) Key words: bronchoalveolar lavage-phagocytosis * pulmonary macrophage Introduction Immune complexes have been identified in the sera of cystic fibrosis (CF)' patients with a reported incidence that varies from 23% to 86% (1) (2) (3) (4) . The occurrence ofcirculating immune complexes (IC) is thought to be related to respiratory exacerbations (1, 2) , deteriorating pulmonary function (2, 3) , age of CF patients (1) , the presence of chronic airways infection caused by Pseudomonas aeruginosa (PA; reference 4) and associated with significant increases in IgG antibody to pseudomonas (2) . The observation of increased IC concentrations in sera, lung tissues (5, 6) , and sputa (4) of CF patients with chronic pseudomonas infection and the poor prognosis of these patients (7) may point to local IC formation in the lungs. We and others have suggested that defective CF serum opsonophagocytosis may be related to defective Fcy function ofCF IgG antibodies (8) , or that an IgG2 subclass response, a subclass with a low affinity for pulmonary macrophages (PM) Fc-receptors, may contribute to defective cellular clearance of PA from the human airway (9) . PA may persist in the airways, exerting a stimulus for production of high titers of IgG2 antibodies, resulting in appropriate conditions for IC formation.
We propose that IgG2 antibodies in high concentrations selectively inhibit clearance of PA by PM. If this is observed, it follows that the predominant immunoglobulin component of CF IC would be IgG2. Furthermore, IC may competitively inhibit effective phagocytosis of opsonized PA cleared through PM Fc-receptor binding. The present studies measured the IgG subclass contribution to CF IC and employed an in vitro phagocytic assay of normal human PM and neutrophils to study the phagocytosis of a '4C-tagged clinical isolate of mucoid PA. We found an inhibition of the phagocytic process by IgG2-containing IC.
Methods
Subjects and serum specimens. Sera obtained from 18 CF young adults with chronic PA colonization ofat least I yr duration were screened for the presence of immune complexes. 10 with the highest IC levels were selected for study in greater detail (CF + IC). There were four females and six males with a mean age of 17.9±1.4 yr (range 10-24 yr). Sera were also obtained (generously provided by Dr. Donald Livsey, Specialty Laboratory, Inc., Los Angeles, CA) from 11 non-CF patients with significant elevations of IgG2 (IgG2 = 1,088±119 mg/dl, > 2 SD above normal mean). Many of these individuals suffered from allergic respiratory symptoms or chronic airways infections. All sera samples were obtained in the outpatient setting during routine follow-up visits. None ofthese patients were receiving antibiotics at the time serum was obtained. Control sera were obtained from healthy laboratory personnel ("NS", n = 4). PA hyperimmune serum (PAIS) was provided by Parke-Davis, Morris Plains, NJ and consisted of pooled serum from normal volunteers vaccinated with PA heptavalent lipopolysaccharide (LPS) vaccine (Pseudogen vaccine, Parke-Davis). All sera were stored at -70°C if not used within 48 h; samples for more immediate use were maintained at 4°C. Isolation, measurement, and dissociation ofIC. IC levels in CF sera were measured by a Clq solid-phase competitive binding assay (10) performed as a courtesy by the laboratory of David P. Huston, MD (Baylor College of Medicine, Houston, TX). All samples were run in triplicate and the results expressed in milligrams per deciliter.
Complexes were precipitated from serum by 2.7% polyethylene glycol 6000 (PEG) after the methods of Berdischewsky et al. (1) . At 4VC 2 vol of serum were mixed with 1 vol of 8% PEG in PBS (wt/vol, pH = 7.2) for 1 hr, then precipitated at 1,000 g at 40C for 1 hr. The pellet was washed in 2.7% PEG and resuspended to one-half the original serum volume in a dissociating solution of 0.1 M glycine/HCI, pH 3.0.
The serum supernatants were preserved for use later in an hemagglutination assay (HA) and a phagocytic assay. The solution containing partially purified and resuspended IC was used in the hemagglutination assay, in an enzyme-linked immunosorbent assay (ELISA) to quantify total IgG precipitated, and in the phagocytic assay in "add back" experiments in which IC were returned to the original serum supernatants. Our own data (unpublished) and the work of others ( 11) suggest that there is increasing precipitation of noncomplexed IgG and other proteins with higher concentrations of PEG, but the contamination is insignificant below 6% PEG concentrations. It was determined, however, that 0.1 M glycine/HCl, pH 3.0 or pH 7.0, and PEG both had inhibitory effects on endocytosis of opsonized bacteria. Therefore, the reconstituted IC serum was dialyzed against borate (0. 16 Isolation ofmacrophages and neutrophils. This technique was similar to that used in previous reports from this lab (14) . Briefly, the day before each planned phagocytic assay informed consent was obtained from a patient undergoing diagnostic bronchoscopy and bronchoalveolar lavage was performed in uninvolved lobes of lung. All patients were smokers and otherwise in good health at the time of the procedure. Smokers were selected because prior studies have shown that the phagocytic competence of PM is not affected by smoking (15) and a larger number of PM can be obtained from these individuals. Subsegmental lavage of the right middle lobe and/or the lingula was performed by instilling 20-ml aliquots of sterile 0.9% NaCl and immediately aspirating with low wall suction (-80 cm H20) for a total volume of 100 ml at each site. Lavage fluid return was routinely 60-70% of instilled volume.
PM were isolated as per our routine lab protocol (8, 14) . The 4VC , supernatants were removed, and chilled 2 mM NaF was added to assure termination of phagocytosis. Phagocytic cells were washed and then digested using 0.5 N NaOH at 37°C for 18 h, and cell-associated counts were determined in a liquid scintillation counter after neutralizing NaOH with 3% acetic acid.
To quantify the PM and neutrophil uptake of '4C-labeled PA, the mean specific activity of the initial inoculum of '4C-labeled PA was determined. The 
Results
Concentrations of IC, serum IgG, and antibody titers to PA antigen. The mean IC concentration in the CF + IC sera was 2.90±0.22 mg/dl (Table I ). In this assay system four normal sera revealed a mean level of 0.62±0.12 mg/dl (CF + IC vs. normal sera, P < 0.01). The total IgG concentration deter- IgG2 concentrations in CF + IC sera were reduced to the upper limit of the normal range, 766±123 mg/dl, after removal of IC (Table II , column 4, final line). This was a significant decrease when compared to 1,178+192 mg/dl IgG2 concentration in the intact CF + IC sera (P < 0.01). This resulted in a shift in the relative IgG2 content from 42.0% to 31.5% and the overall relative proportions of the four subclasses in CF sera also returned to normal values. The changes in relative proportions of other subclasses after precipitation of IC were not significant.
Pulmonary macrophage clearance ofP. aeruginosa. Results of the in vitro phagocytic assay using PM (Table III) (Table IV A, "Supernatant Control"). PEG precipitation of other opsonizing sera (NS, PAIS, and NaCl) also had no effect to augment bacterial uptake (Table III) .
Neutrophil clearance of P. aeruginosa. Results of the in vitro neutrophil phagocytic assay (Table III, right side) for PAIS, NaCl, and NS opsonins were consistent with their relative IgG hemagglutinating titers to PA LPS. Despite high titers to PA LPS, once again, the sera from the CF + IC group were less potent as opsonins compared to normal sera (CF + IC = 16.9% vs. NS = 23.6%, P < 0.01). PEG precipitation of IC from the CF + IC sera enhanced the mean ['4CJPA uptake by neutrophils from 16.9% to 52.6% (Table III , last line, P < 0.01). The latter level was more consistent with the high serum titer to PA LPS in the CF + IC samples. Using the same approach as for the PM assay, this observed augmentation was reversed by adding the IC back to the original supernatants (Table IV B , column 3) . Similarly, adding IC to the PAIS caused a significant reduction in uptake from 85.1% to 39.5% (Table IV B , P < 0.01). This result was specific for CF IC. When identically prepared 2.7% PEG precipitate from PAIS serum was added to the PAIS supernatant, bacterial uptake was 75.8%, which was not significantly different from baseline uptake of 85.1% (Table IV B (Table III) .
IgG2 effect on macrophage and neutrophilphagocytosis. In an attempt to provide corroborative data supporting the inhibitory effect of IgG2 on phagocytic cell uptake of P. aeruginosa sera specimens obtained from individuals with high IgG2 levels were employed with an in vitro assay of opsonophagocytosis. High IgG2 levels in the opsonic serum significantly inhibited uptake of '4C-tagged PA in both the neutrophil (IgG2 = 40.9±0.8% vs. NS = 48.3±0.6%, P < 0.01) and pulmonary macrophage (IgG2 = 6.8±0.1% vs. 23 .9+2.4%, P < 0.01) systems (Fig. 1 a) . These results were unaffected by heating at 56°C for 30 min. In separate experiments (Fig. 1 b) , removal of IgG2 from four of these sera samples by affinity chromatography resulted in a 51% increase in PM phagocytosis of the ['4C]PA (IgG2 = 38.3±0.3% vs. minus IgG2 = 57.9±0.6, P < 0.01). There are poorly characterized inhibitory factors in CF serum, associated with chronic P. aeruginosa infections, which impair phagocytosis of PA. These factors effectively negate the impressive IgG titers to PA antigens found in CF sera which should be protective. In fact, IgG titers to PA antigens paradoxically correlate with clinically worsening pulmonary disease (8, (17) (18) (19) . Recently, our laboratory has implicated IgG2 causally in this process by suggesting that it may act as a "blocking antibody" specific to pulmonary macrophages (9, 20) . The data presented here permit extension of this concept. These observations corroborate the earlier findings that IgG2 exerts an independent inhibitory effect in an in vitro phagocytic assay using PM.
The concept ofblocking antibodies is controversial and has been suggested to explain the role that allergen specific IgG plays in preventing IgE antibody-mediated allergy to bee venom. In this situation, subclass IgG4 has been the potential mediator of the blocking effect by coating the offensive antigen, preventing it from binding to IgE (21) . Importantly, G4 may be protective by virtue of the fact that, like IgG2, it has a low affinity for complement and Fc receptors on macrophages and lymphocytes (22) . In this report we proposed an analogous mechanism involving IgG2 to account for the decreased clearance ofpseudomonas in CF by PM. LPS, a prominent cell wall component common to gram-negative bacilli, is a key antigen for the humoral recognition and clearance of this pathogen (23) (24) (25) . Our work has demonstrated that the IgG subclass response to PA LPS is restricted largely to IgG2 (9) . IgG responses to many polysaccharide antigens are known to be restricted to subclass 2 (reviewed in reference 26). In patients with elevated serum IgG2 concentrations, such as CF patients (9) , the predominant subclass coating PA may be IgG2. We reasoned that phagocytosis by human PM, which have Fc receptors recognizing predominantly IgG3 and to a lesser degree IgG 1 (27, 28) , would be less effective in binding and, therefore, clearing organisms opsonized by serum with elevated IgG2 (9, 20) . This proposed mechanism for monomeric IgG2 may account for the inhibition of PM phagocytosis that reverses when the elevated IgG2 concentration is reduced as shown in Fig. 1 (9) and in the present study we found that the HA titer to PA LPS was strikingly elevated in dissociated IC precipitated from CF + IC sera. The CF + IC sera also had a significant IgG2 subclass predominance in the precipitated IC.
It may be that IC may partially account for elevation in serum IgG2 reported previously (9, 32 The use of PEG to precipitate IC has been criticized because it nonspecifically precipitates small amounts of serum proteins other than IC (35, 36) . This problem was minimized in our studies by (a) using a low PEG concentration of 2.7% (up to 6% has been cited as selectively precipitating immune complexes) (11) , (b) avoiding repetitive freezing and thawing of serum which tends to cause IgG and other serum proteins to aggregate and precipitate with PEG (37), and (c) when possible, maintaining serum at 4°C to be used within 48 h.
The role of immune complexes in the pathogenesis of CF lung disease has been addressed by several authors with inconclusive results (6, 33, 34, 38) . A possibility, not investigated here, is that the antigenic components of circulating IC may interfere with phagocytic cell endocytic function. It may be that the IC identified above and the monomeric IgG2 antibodies together provide explanations for the persistence of P. aeruginosa in CF airways. IC in CF serum may exert an inhibitory effect on both PM and neutrophil phagocytosis of PA by competing with opsonized bacteria for Fcy receptor sites on the surface ofthese phagocytes. This may be a situation analogous to the often invoked but poorly documented IgG4 blocking antibody mechanism for allergen desensitization (discussed above). Therefore, bacteria-IgG2 complexes may contribute to the pathogenesis of CF lung disease through a mechanism other than complement activation. The results presented in Table 3 
